Form 4: Assembly Biosciences Director Receives New Stock Option Grant

Assembly Biosciences, Inc. Director John G. McHutchison was granted 3,500 stock options with an exercise price of $15.81, aligning his interests with shareholder value.

Summary

• John G. McHutchison, a Director of Assembly Biosciences, Inc. (ASMB), was granted 3,500 stock options.
• The options have an exercise price of $15.81 per share.
• The transaction date for this grant was June 5, 2025.
• The stock options are exercisable upon the earlier of June 5, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, assuming continuous service.
• The options have an expiration date of June 5, 2035.
• Following this transaction, Mr. McHutchison directly beneficially owns 3,500 derivative securities (stock options).

Sentiment

Score: 6

Explanation: Slightly positive. While it introduces potential future dilution, the grant of options to a director is a standard practice that aligns the director's interests with shareholder value, indicating continued commitment.

Positives

• The grant of stock options to a director helps align management's interests with those of shareholders, as the options gain value if the company's stock price increases.
• It represents a standard form of compensation, indicating continued commitment and incentivization for the director's service.

Negatives

• The issuance of new stock options introduces potential future dilution for existing shareholders if and when these options are exercised.

Future Outlook

The stock options are set to vest by June 5, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, contingent on the director's continuous service, providing a future incentive for performance.

Management Comments

• The grant of stock options to Director John G. McHutchison reflects a compensation decision by the company to incentivize and retain key leadership.

Industry Context

The granting of stock options to directors is a common practice across various industries, particularly in biotechnology and growth-oriented companies, to align the interests of leadership with long-term shareholder value creation.

Related Party Transactions

• The document reports the grant of 3,500 stock options to John G. McHutchison, a Director of Assembly Biosciences, Inc., which is a transaction between the company and a related party (an insider) as part of his compensation.

Stakeholder Impact

• Shareholders: Potential for minor future dilution if options are exercised, but also improved alignment of director's interests with shareholder value.
• Employees: No direct impact on general employees mentioned in this filing.

Next Steps

• The stock options will vest upon the earlier of June 5, 2026, or the date of the Issuer's 2026 annual meeting of stockholders, assuming continuous service.

Key Dates

Keywords

Assembly Biosciences, ASMB, Stock Options, Insider Transaction, Form 4, Director Compensation, Equity Grant, SEC Filing